Western blot analysis of MAD2L1BP expression in A431 cell lysate.
| A03070 | |
|
|
|
| ¥37,309.00 | |
|
|
|
|
|
|
| Ask us a question | |
| Specificity | This product is specific to MAD2L1BP |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human MAD2L1BP |
| Species Reactivity | Human; Mouse; Rat |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||
|
|||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of MAD2L1BP expression in A431 cell lysate.
| Target Background | May function to silence the spindle checkpoint and allow mitosis to proceed through anaphase by binding MAD2L1 after it has become dissociated from the MAD2L1-CDC20 complex. |
| Synonyms | Caught by MAD2 protein; CMT2; KIAA0110; MAD2L1 binding protein; MAD2L1-binding protein; MAD2L1BP; MD2BP; MGC11282; RP1-261G23.6; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
